#Clinical Research Organisations
Explore articles tagged with Clinical Research Organisations
Licensed in Germany, Ready for Europe
HRV Pharma's acquisition of Germany-based Phatebo GmbH provides an established entry into the European pharmaceutical market. With German pharmaceutical wholesale authorisation, good distribution practice systems and an existing global customer base, the acquisition supports HRV's expansion into finished formulations while strengthening its international presence.
Keeping Clinical Trials on Schedule
HRV Pharma's acquisition of Germany-based Phatebo expands its business into clinical trial supply and finished formulations. Phatebo provides investigational, comparator and ancillary medicines through licensed channels, with traceability of origin, batch and expiry to support reliable clinical trial operations.
Into Clinical Trial Supply
HRV Pharma has expanded beyond APIs into clinical trial supply through its acquisition of Germany-based Phatebo. The company sources comparator, investigational and ancillary medicines for pharmaceutical companies and CROs worldwide, bringing HRV into a segment where reliability, traceability and timely delivery are essential.